ArticleBioinformation2026
Global longitudinal strain for early detection of subclinical left ventricular systolic dysfunction in patients with systemic lupus erythematosus at a tertiary care centre: A hospital-based study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic Lupus Erythematosus (SLE) silently affects cardiac function, requiring early myocardial dysfunction detection to prevent morbidity. This hospital-based cross-sectional study assessed 49 SLE patients (2019 ACR/EULAR criteria) via clinical exam, Electrocardiogram (ECG) and echocardiography including speckle-tracking Global Longitudinal Strain (GLS). Evaluated parameters included Left Ventricular Ejection Fraction (LVEF), diastolic function, valvular lesions, pericardial effusion, pulmonary pressures and GLS (values < -16% indicating subclinical systolic dysfunction). Abnormal GLS occurred in 55.1%, with 28.5% showing preserved LVEF but impaired GLS, alongside systolic dysfunction (63.2%) and diastolic dysfunction (14.2%). GLS advances SLE cardiac screening by detecting subclinical LV impairment before LVEF decline, enabling timely intervention in preserved ejection fraction patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.